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Feeding small for gestational age (SGA) newborns is extremely challenging and the neonatologist should be brave
and cautious at the same time. Although these babies have a high risk of milk intolerance and necrotising
enterocolitis, enteral feeding guidelines are not well established and practice varies widely among different
neonatal units. Currently available studies on this topic include extremely and very low birth weight neonates, but
are not focused specifically on small for gestational age infants. This review analyzes papers focused on feeding
interventions in order to provide the best available evidences about the optimum timing for introduction of enteral
feeding, how fast feed volume can be advanced, which milk and which feeding method is more appropriate in
SGA infants.
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The term “small for gestational age” (SGA) is used to de-
scribe newborns whose birth weight and/or crown-heel
length is less than expected for their gestational age and
sex. Traditionally, the term SGA has been used to de-
scribe a neonate whose weight and/or length at birth is
at least 2 SD below the mean for the infant’s gestational
age, equivalent to the 2.3 percentile, based on the data
derived from an appropriate reference population [1].
Some publications define SGA newborns as those with
birth weight or length below the 3rd, 5th, or 10th per-
centiles for gestational age [2]. The first definition was
chosen by the international SGA advisory panel because
it likely includes the majority of patients with impaired
fetal growth.
However, this definition of SGA is inaccurate because
it is not able to exclude the constitutional smallness,
which is not pathological [3]. The term intrauterine
growth retardation (IUGR) suggests diminished growth
velocity in the fetus as documented by at least 2 intra-
uterine growth assessment. Therefore SGA and IUGR
are not synonymous. IUGR indicates the presence of a
pathological process occurring in utero that inhibits fetal
growth. Being born SGA does not necessarily mean that
an intrauterine growth retardation has occurred and in-
fants who are IUGR are not inevitably SGA at birth.* Correspondence: gbarone85@yahoo.it
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reproduction in any medium, provided the orThere are several causes for being SGA. Exposure of
the fetus to toxins (smoking, alcohol, drug abuse),
chromosomal anomalies (trisomy 13, Edward Syndrome,
Turner Sydrome, Prader-Willy Syndrome etc.), congeni-
tal infections (toxoplasmosis, rubella, cytomegalovirus),
metabolic disorders, maternal factors (both young and
advanced age, maternal hypertension, placental and uter-
ine abnormalities etc.). However the most common eti-
ology of being born SGA is placental insufficiency that
impairs growth particularly during the last trimester of
pregnancy leading to IUGR [4-6]. Below we discuss the
most severe and important complication for these neo-
nates, with pathophysiological considerations.NEC
Necrotizing enterocolitis (NEC) is a severe inflammatory
disorders in which prematurity and enteral feeding
seems the major predisposing factors. It occurs in up to
7% of very low birth weight infants, with a mortality rate
of 15 - 30%, inversely related to birth weight and gesta-
tional age [7]. Garite et al. in a retrospective study in-
cluding 29.916 premature newborns found that both
SGA and IUGR were independently associated with an
increased risk of NEC [8] By the physiological point of
view growth restriction modifies the developmental
pattern of intestinal structure. The intestine of SGA neo-
nates has reduced weight, length, wall thickness, villous
weight, and crypt depth [9,10]. Furthermore these
infants have intestinal dysbiosis and an alteration of theLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Barone et al. Italian Journal of Pediatrics 2013, 39:28 Page 2 of 5
http://www.ijponline.net/content/39/1/28proliferation-apoptosis homeostasis which leads to a
reduced surface of intestinal exchange [11]. These
alterations could be responsible for the higher gastro-
intestinal morbidity, feeding intolerance and impaired
nutrient absorption.
However recently much attention was focused on
those infants born prematurely with IUGR and abnormal
blood flow on antenatal Doppler studies [12]. Increased
placental resistance in the presence of placental failure
leads to a reduction in end diastolic blood flow through
the umbilical arteries, progressing to absent (AEDF) or
reversed flow (AREDF) [13]. Pathophysiology of fetal
adaptation to chronic hypoxia involves preferential
shunting of blood to the brain at the expense of the
splanchnic circulation. It was shown that severe prenatal
Doppler abnormalities are associated with poor fetal out-
come [14,15], but it is still debated if they increased the
risk of neonatal NEC.
Some studies have demonstrated a close association
between AEDF or AREDF and NEC, which appears to
be independent of other factors such as degree of growth
retardation, prematurity and perinatal asphyxia [16,17],
while others have not confirmed these findings [18,19].
A meta-analysis of 14 observational studies demon-
strated an increased incidence of NEC in preterm infants
who had suffered fetal AREDF compared with controls,
with an odds ratio of 2.13 (95% CI 1.49 to 3.03) [20].
Nine of the included studies showed an excess of NEC
in the AREDF infants; eight studies classified NEC using
the stricter definition of radiological or surgical confirm-
ation, of which six showed an excess of confirmed NEC
in the AREDF group. Overall, confirmed NEC was not
significantly increased in these studies (OR 1.6, 95% CI
0.9 to 2.8), but the six studies examining confirmed NEC
in preterm infants with IUGR showed greatly increased
odds of confirmed NEC in infants with fetal AREDF (OR
6.9, 95% CI 2.3 to 20). In many of the studies, fetuses
with AREDF required earlier delivery than controls so it
could be argued that the higher risk of NEC in these
studies was primarily related to the lower gestational age
and birth weight; nevertheless, the excess of confirmed
NEC was also found in the two series that matched con-
trols for gestation and weight (OR 5.5, 95% CI 1.1 to 28)
[16,21]. A more recent study confirmed the results of
this meta-analysis demonstrating a strong relation be-
tween AREDF and subsequent development of NEC
(OR: 5.88, 95% CI: 2.41 to 14.34) also after adjustment
for gestational age at birth (OR: 7.64, 95% CI: 2.96 to
19.70,) and after adjustment for birth weight for gesta-
tional age z-score (OR: 6.72, 95% CI: 2.23 to 20.25) [22].
All the previous studies examined only the role of um-
bilical arteries Doppler flows. When Manogura et al. [23]
investigated a more comprehensive fetal Doppler assess-
ment that provided greater circulatory details (umbilicalartery, middle cerebral artery, ductus venosus, and umbil-
ical vein) the association between NEC and AREDF was
lost. In this study, a multinomial logistic regression with
NEC as dependent variable failed to demonstrate a rela-
tionship between placental resistance and the risk of NEC,
and found that birth weight and base deficit at birth were
the independent risk factors for NEC. These results have
raised some doubts on the reliability of all the evidences
suggesting a causal relationship between NEC and abnor-
mal placental resistance. Moreover, many studies were
underpowered given the overall low incidence of NEC,
and the metabolic status at birth was not taken into con-
sideration by any of these studies. If it is plausible that pla-
cental insufficiency predisposes to, but does not initiate,
the cascade of events that lead to NEC, it is more likely
that the limitations of prematurity define the origins of
this disease.
The questions about feeding SGA infant
Enteral feeding guidelines are not well established in
preterm SGA neonates, and there is a lack of published
information about best feeding regimen. Practice varies
widely among different neonatal units as shown by a
survey carried out in two different English Health Re-
gions, but a policy of delayed and careful introduction of
enteral feeding is often chosen in order to prevent NEC
[20]. We now analyze the best current evidences on
feeding SGA infants.
What milk
Human breast milk would be expected to protect against
NEC for its antimicrobial and anti-inflammatory charac-
teristics. However, proving efficacy in randomized clin-
ical trial has been challenging because of 2 main reasons.
First of all, the difficulty of recruiting infants to a random-
ized trial about human milk when mothers have strong
preferences, secondly the lack of standardized definitions
of what human milk comprises (maternal or donor,
fortified or unfortified, human milk alone or human milk
plus formula).
In 1990 Lucas and Cole demonstrated a reduction in
the incidence of NEC among preterm infants who re-
ceived only human milk when compared with infants
who received bovine milk–based formula [24]. Two
meta-analysis of several small randomized controlled tri-
als reported a lower incidence and severity of NEC in in-
fants fed with an exclusively human milk diet [25,26]. A
recent trial randomized 207 premature infants with a
birth weight between 500 and 1250 grams to receive for-
tified human milk or bovine-milk based products and
confirmed earlier data finding that the rates of NEC and
NEC requiring surgery were markedly lower in the first
group. The number of infants needed to treat (NNT)
with an exclusively human milk diet to prevent 1 case of
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NEC or death is 8 [27].
Early vs delayed
Early enteral feeding is advantageous because it im-
proves the functional adaptation of the gastrointestinal
tract by stimulating hormone secretion and gastrointes-
tinal motility [28]. It also decreases the need of total par-
enteral nutrition and its associated complications, such
as catheter related sepsis, cholestasis, cardiac tampon-
ade, osteopenia of prematurity and other metabolic dis-
turbances [29,30]. Despite this, early enteral feeding is
often delayed in high risk infants because it has been
thought to be associated with an increased risk of NEC.
A meta-analysis of five RCTs conducted on preterm in-
fants did not detect a significantly different risk of NEC
between infants randomized to delayed feeding (defined
as introduction of enteral feeds as later than day 5–7 after
birth) and infants randomized to early feeding (defined as
less than 4 day after birth); RR 0.89 (95% CI 0.58 to 1.37)
[31]. The two largest trials in that meta-analysis [32,33]
recruited only SGA infants with abnormal fetal circulatory
distribution or flow. For these reasons, data from these tri-
als do not provide sufficient evidence that delayed intro-
duction of enteral feeding in SGA neonates reduces the
risk of NEC, even if 95% CI for the pooled estimates of ef-
fect is wide and consistent with more than 40% reduction
in the risk of NEC and death in newborns who have de-
layed introduction. Given this level of uncertainty this
findings should be applied cautiously.
Minimal enteral feeding
An alternative approach to delaying feeding is the
minimal enteral feeding (MEF). MEF (also known as
“trophic feeding”, “gut-priming”, “non nutritive feeding”
and “hypocaloric feeding”) is conventionally defined as
giving small volumes of milk (typically 12 to 24 ml/kg/
day every 1–3 hours) starting within the first few days
after birth without advancing the feed volumes during
the first week of life [34]. Enteral fasting during the early
neonatal period has potential disadvantages for prema-
ture infants, because gastrointestinal hormone and mo-
tility are improved by enteral milk. Delayed enteral
feeding could impair the functional adaptation of the
gastrointestinal tract leading to intestinal dismotility and
consequent feeding intolerance [35,36]. A systematic re-
view published in the Cochrane Library [37] did not de-
tect a statistically significant effect on the incidence of
NEC between very low birth weight newborns random-
ized to MEF and to no enteral feeding (RR 1.07 95% CI
0.67 to 1.70). Substantial clinical uncertainty remains
about the effect of MEF on SGA infants because most of
the trials on this topic specifically exclude infants who
were SGA at birth. The only one including 56 babieswith birth weight below 2000 grams and below 10th per-
centile for gestational age failed to demonstrate signifi-
cant differences between newborns fed with trophic
feeding or no feeds for the first five days of life in the
primary outcome of intestinal permeability measured by
the sugar absorption test [38]. There were also no differ-
ences in feeding tolerance, growth and incidence of NEC
between the two groups [38].
How to advance feed volume
The rate of advancement of enteral feeding is another
area of uncertainty. Retrospective studies have found
that those neonatal centers where enteral feeding is in-
troduced earlier and feeding volume advanced faster
have higher incidences of NEC [39]. On the other hand,
slow advancement of enteral feeding delays the estab-
lishment of full enteral nutrition and extends the dur-
ation of total parenteral nutrition with its associated
risks [40], that may have adverse consequences for sur-
vival, growth and development [41]. A meta-analysis of
four trials (496 very low birth weight infants) showed no
differences in NEC rates comparing rapid (as 30 to 35
ml/kg/day) versus slow (as 15 to 20 ml/kg/day) advance-
ment feeding strategies (RR 0.91 95% CI 0.47 to 1.75)
[42]. Infants fed at faster rate reached the full enteral
feeding about two to five days earlier than infants fed
slowly, but they did not have a higher risk of NEC. How-
ever, these findings should be applied with caution to
SGA newborns because the vast majority of the studied
infants were appropriate for gestational age. Only in the
trial performed by Salhotra et al. [43] more than 95% of
the 53 participants were SGA. In this trial, the fast en-
teral feeding group reached the full enteral feed signifi-
cantly earlier (mean 10 days) than the slow advancement
group (mean 14.8 days), and there were two cases of
NEC in the fast advancement group. To date there are
no trial that compare slow versus fast feeding regimen in
a selected population of SGA newborns.
Mode of feeding
To date there are no studies focused on SGA newborns
and the best mode of feeding. The few available data
concern premature infants born < 1500 grams that are
not able to coordinate sucking, swallowing, and breath-
ing. A systematic review of seven trials published in the
Cochrane Library [44] did not detect a statistically sig-
nificant effect between continuous versus intermittent
milk feeding methods in time to achieve full enteral
feeding, in feeding intolerance, in somatic growth and in
incidence of NEC. At the present time practice appears
to be based more on individual assessment rather than
on scientific evidence. Continuous feeding may reduce
energy expenditure [45] and improve feeding tolerance,
nutrient adsorption and growth [46]; on the other hand,
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promoting the cyclical pattern of release of gastrointes-
tinal hormones, which are important for gut develop-
ment [47].
Feeding intolerance
Feeding intolerance is usually characterized by gastric
residuals before feeding, emesis and abdominal disten-
tion. The gastric residual volume (GRV) is the element
of feeding that can be measured and compared most
easily. Several authors suggested to use GRV as a marker
of feeding intolerance, in order to make early detection
of NEC [48-50]. Qualitative and quantitative evaluation
of gastric residuals can be performed. To date is difficult
to assess a tolerance threshold of GRV beyond which
enteral feeding should be withdrawn. Mihatsch et al.
[48] tolerated GRV up to 2 mL in newborns ≤ 750 grams
and up to 3 mL in newborns from 750 to 1000 grams in
their protocol, but concluded that additional research is
required to evaluate if GRV threshold could be increased
up to 5 ml/kg body weight. Cobb et al. [49] found that
GRV > 3.5 mL or 33% of a single meal may be associated
with a higher risk for NEC while a GRV <1.5 mL or 25%
of a meal is probably normal. Finally the available data
on qualitative evaluation of gastric residuals suggest that
infants with blood stained or hemorrhagic residuals were
at higher risk of NEC, whereas bile stained residuals are
not a risk factor by themselves [50].
Quality of the evidence
Being born SGA does not necessarily mean that IUGR has
occurred, and infants who are IUGR are not inevitably
SGA at birth. Unfortunately, the terms IUGR and SGA
have been used interchangeably, creating confusion on the
topic. In the absence of congenital malformations or
chromosomal abnormalities, small fetal size could be the
consequence of two distinct processes: constitutional
smallness or pathological growth restriction. Distinguishing
one process from the other is challenging, but such distinc-
tions have profound implications toward understanding
quality and robustness of evidence provided by available
trials. Patients enrolled in the studies are usually selected
according to their birth weight (below the 10th or the 3rd
percentile) without checking if a growth restriction really
occurred. So SGA is a term that is often used as a proxy
for restricted growth, thereby combining both constitution-
ally small and pathologically growth restricted fetuses. It is
known that growth restricted fetuses are small because of
some underlying pathological conditions (smoking during
pregnancy, uteroplacental dysfunction, hypertensive disor-
ders, etc.), and they are therefore at increased risk for
neonatal morbidity and mortality. On the other hand,
constitutionally small infants can easily have morbidity and
mortality very similar to appropriate for gestational age,and considerably lower than pathologically growth re-
stricted ones [51].
Conclusions
There is limited evidence on which to base feeding pol-
icy in SGA newborns. Currently available studies on this
topic include extremely and very low birth weight neo-
nates, but are not focused specifically on SGA infants.
Furthermore there are not RCTs that make a clear dis-
tinction between SGA and growth restricted neonates.
Future randomized trials on feeding intervention should
be targeted on IUGR infants, excluding constitutionally
small newborns, in order to provide robust evidence
concerning the optimum timing for introduction of en-
teral feeding, how fast feed volume can be advanced and
which feeding method is more appropriate. To date,
however, no trials showed any benefits of delayed enteral
feeding or slow advancement of enteral feed volumes.
Growth restricted newborns are a nutritional emergency
that will result in serious short and long term detrimen-
tal effects, when left untreated.
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